SMTL ID : 3ztd.2 (3 other biounits)

pVHL54-213-EloB-EloC complex _ methyl 4-(((2S,4R)-4-hydroxy-1-(2-(3- methylisoxazol-5-yl)acetyl)pyrrolidine-2-carboxamido)methyl)benzoate

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.79 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x ZTD: METHYL 4-[({(4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-L-PROLYL}AMINO)METHYL]BENZOATE(Non-covalent)

ZTD.1: 11 residues within 4Å: Chain C: N.16, W.37, F.40, Y.47, P.48, R.56, H.59, S.60, Y.61, H.64, W.66 10 PLIP interactions: 10 interactions with chain C Hydrophobic interactions: C:W.37, C:Y.61, C:W.66 Hydrogen bonds: C:Y.47, C:H.59, C:Y.61, C:H.64 Salt bridges: C:R.56 pi-Stacking: C:Y.47, C:Y.61

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Van Molle, I. et al., Dissecting Fragment-Based Lead Discovery at the Von Hippel-Lindau Protein:Hypoxia Inducible Factor 1Alpha Protein-Protein Interface. Chem.Biol. (2012)

Release Date

2012-07-25

Peptides

TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2: A
TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1: B
VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

B
E

C
F

TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2

TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1

VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR

Related Entries With Identical Sequence